TB Research

Disseminated BCGitis after intravesical Bacillus Calmette-Guérin therapy in a patient with bladder cancer

Marcin Skowroński, Paweł Halicki, Anna Halicka

Polskie Archiwum Medycyny Wewnętrznej · 2024-03

Abstract

A 58-year-old male was admitted to the tuberculosis (TB) department with fever, moderate cough, night sweats, weight loss of 10 kg, and loss of appetite. The patient had been receiving intravesical Bacillus Calmette-Gurin (BCG) instillations, for nine months, as immunotherapy for bladder cancer. The high-grade superficial (pT1) urothelial cancer was

MeSH terms

  • Medicine
  • Bladder cancer
  • Immunotherapy
  • Weight loss
  • BCG vaccine
  • Urology
  • Tuberculosis
  • Cancer
  • Internal medicine
  • Surgery